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Esophageal adenocarcinoma (EAC) incidence rates have increased among U.S. men. We 
examined associations between area-level socioeconomic attributes and stage at 
diagnosis, an important prognostic predictor of survival time. Logistic regression models 
were developed to estimate odds ratios (OR) adjusted for age, race, gender and year of 
diagnosis and 95% confidence intervals (CI) for localized and regional versus distant 
stage by census tract and county level socioeconomic attributes. At the county level, a 
high percent of foreign born population was associated with distant stage EAC: >15.4%-
26.6%, (OR=1.15, 95% CI: 1.04–1.28) and >26.6% (OR 1.16, 95% CI: 1.03–1.31). 
Median household income from $40.8-$45.6K (OR=1.14, 95% CI: 1.01–1.28) was also 
associated with distant stage EAC. Conversely, residence in an urban county was 
associated with localized or regional stage EAC (OR=0.90, 95% CI: 0.82–0.98). Findings 
regarding area level disparities in EAC stage may inform cancer control efforts. 
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Chapter 1: Introduction 
 
Esophageal cancer is the twelfth leading incident cancer among men in the United 
States (US) (1). It is estimated that 16,640 men and women (13,130 men and 3,510 
women) will be diagnosed with and 14,500 men and women will die of cancer of the 
esophagus in 2010 (1). The incidence rate for esophageal cancer increased from 1975 
through 2007 in SEER 9 Registries (annual percent change greater than zero, p < 0.05). 
Furthermore, mortality rates significantly increased among US men from 1992 through 
2006, for esophageal cancer is the seventh leading cause of cancer death (2). For the 
recent time period, 1999-2006, the five-year relative survival for EAC was 18.9 percent 
(2), far below the Healthy People 2010 objective 3.15, to increase the proportion of 
people who are living five years after cancer diagnosis to at least 70 percent (3). Most of 
the increasing incidence and death rates are attributed to the rising burden of EAC 
experienced among white males (4,5).  
There are two major histological types of esophageal carcinoma, squamous cell 
carcinoma (SCC) and adenocarcinoma (EAC). EAC is defined as malignancy of the 
esophagus arising from glandular cells present at the junction of the esophagus and 
stomach (1). Over the past 2 decades, the incidence of esophageal adenocarcinoma 
(EAC) has increased more rapidly than any other cancer in the US (1,6). The specific 
reasons for this increase are not yet understood. Since the presence of Barrett’s esophagus 
is essential for the development of most esophageal adenocarcinomas, the increasing 
incidence of esophageal adenocarcinoma may be related to an increasing prevalence of 
Barrett’s esophagus, and its precursor, gastroesophageal reflux (7). In contrast, rates of 
SCC have remained relatively stable (6). 
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Associations between socioeconomic status (SES) and cancer (using measures 
such as income, education, and occupation) have been observed in several studies (8-12) 
based on widely accepted measures of social class (9-11). Although low SES has been 
associated with an increased risk of esophageal adenocarcinoma (9), few studies have 
investigated the basis by which socioeconomic factors are related to the disease. There 
are some indications that low SES may also increase the risk of EAC (9, 10, 12) but 
inconsistent results (9) and the use of different measures of SES make comparisons and 
interpretations difficult. 
 1.1. Diagnosis 
It is thought that chronic inflammation of the esophagus can contribute to the 
mutations found in DNA which eventually lead to esophageal cancer (13). Factors that 
can cause inflammation in the cells of the esophagus include alcohol consumption, bile 
reflux, chewing tobacco, drinking very hot liquids, eating a diet low in fruits and 
vegetables, eating foods preserved in lye, and smoking. Symptoms of esophageal cancer 
usually do not show up until the
 
cancer is fairly advanced (13). They may include 
pain, dysphagia
 
(difficulty swallowing), weight loss, poor appetite with a preference
 
for 
soft foods, pneumonia, and fatigue. A widely-used test in detecting esophageal cancer
 
is 
esophagogastroduodenoscopy (EGD), in which a lighted, fiber-optic tube is passed from 
the mouth into the stomach to visualize abnormalities in the lining of the esophagus and 
stomach. Biopsies (samples of tissue) can be taken during an EGD. Another test in 
detecting esophageal cancer is a barium swallow. This is a radiographic test that can 
show unhealthy areas in the esophagus
 
and stomach after the patient drinks a barium 
contrast agent.
 





(MRI), blood testing, and positron emission tomography (PET)
 
may also be part 
of the testing for esophageal cancer.  
1.2. Stage at diagnosis 
EAC is generally staged into three categories: localized, regional, or distant. In 
localized EAC, cancer has formed and spread beyond the innermost layer of tissue to the 
next layer of tissue in the wall of the esophagus. The cancer is contained to the esophagus 
and has not spread to lymph nodes or any other organs in the body. Localized EAC has 
the best treatment outcome of all three stages if detected early. In regional EAC, cancer 
has spread to the outer wall of the esophagus and may have spread to tissues and/or 
lymph nodes near the esophagus. In distant EAC, cancer has spread to distant lymph 
nodes and/or organs in other parts of the body. The distant stage of EAC has the worst 
treatment outcome and has the highest mortality rate. 
1.3. Risk Factors 
Risk factors for EAC include age, gender, race, family history, obesity, smoking, 
alcohol consumption, and diet (14). A summary of EAC risk factors found in previously 
published literature is located in Appendix I. 
1.3.1. Age 
Studies consistently show that the incidence of EAC increases with age (6, 14-
16). Data from both SEER and the Danish Cancer Registry demonstrate that the 
incidence rate of EAC increases with age until it peaks at 75-79 years of age and declines 
thereafter (14). 
1.3.2. Gender 
Male gender is a well-recognized risk factor for EAC. It is estimated that the 




White race has long been associated with EAC. Kubo and Corley found that the 
average annual incidence rate for EAC for white men was double that of Hispanic men 
(4.2 versus 2.0/100,000/year). This rate was also four times higher than that seen in 
black, Asian/Pacific Islanders, and Native Americans. 
1.3.4. Family History 
Several small studies suggest the possibility of an autosomal dominant inheritance 
pattern of EAC (14, 16). Larger case-control studies come to less clear-cut conclusions 
(14). Chak et al. found that a positive family history was higher among cases with 
Barrett’s esophagus, EAC, or gastroesophageal junction carcinoma than among controls 
(24% versus 5%). 
1.3.5. Obesity 
The rapid increase in the incidence of EAC parallels the rise of obesity in the 
Western world (14). As a result, obesity has emerged as a leading candidate risk factor 
for EAC. Kubo and Corley found that a BMI greater than 25 was associated with an 
increased risk of EAC in both men (OR 2.2; 85% CI, 1.7 – 2.7) and women (OR 2.0; 
95% CI 1.4 – 2.9) and higher levels of BMI were associated with increased risk. 
1.3.6. Smoking 
Several studies have identified current or past smoking as a risk factor for EAC 
(6, 14-17). The risk increases with increasing intensity and duration of smoking (14). 
1.3.7. Alcohol Consumption 
Most epidemiologic studies find no association between alcohol consumption and 
EAC (14). However, several studies do find a modest association of alcohol consumption 
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and risk of EAC (6, 14, 18). Overall, alcohol does not seem to be a major risk factor for 
EAC (14). 
1.3.8. Diet 
A diet high in carbohydrates may be linked to EAC. A recent ecologic study 
found a correlation between the rise in carbohydrate consumption with the increase in 
EAC rates (19). On the contrary, a diet rich in fruits and vegetables is consistently 
associated with a decrease in the risk of EAC (19). 
 1.4. Main EAC Risk Factors: GERD and BE  
Gastroesophageal
 
reflux disease (GERD) is the first disease present in the EAC 
pathway. GERD exhibits the same symptoms as heartburn, leaving the affected 
individual with an uncomfortable burning feeling in the chest area (20). Individuals with 
GERD may choose to either temporarily ignore their symptoms, self-medicate, or take 
secondary preventive measures such as proton-pump inhibitors (20). For example, the 
prescription Nexium is an inexpensive, proton-pump inhibitor which is covered by most 
basic health insurance. Those without health insurance may still be able to afford the 
inexpensive medication or obtain low-cost generic versions. If left untreated, GERD can 
evolve into Barrett’s esophagus (BE), a much more serious disease where normal 
esophageal cells change into gland-like adenomatous cells. BE is defined as metaplasia in 
the cells of the inferior portion of the esophagus (18). Epidemiological studies conducted 
in the US suggest that the prevalence of BE in the general population is approximately 
1%, however, only a small number of these cases are actually diagnosed within a 
patient’s lifetime (21). 
BE is more difficult to detect and requires more complex screening methods. At 
this stage of disease progression, health insurance is almost mandatory to cover the high 
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costs of screening procedures. Without health insurance, it would be very difficult to 
meet the financial burden presented by these screening methods; therefore, those who are 
uninsured usually ignore or cope with symptoms. Over-time, symptoms progress into 
more unbearable pain, difficulty swallowing, etcetera. At this point, patients who have 
not received previous screening are more likely to get screened due to the intensity of 
their symptoms. By this time, it is too late for most cases as the disease has spread to the 
distant stage and will not only require more aggressive treatment, but will have a worse 
prognosis. 
1.5. Screening 
Because the esophagus is located near other vital anatomic structures, EAC is 
most manageable when detected early. Several screening techniques are currently in use 
to help detect both EAC and its precursor (BE) including esophagoscopy, biopsy, brush 
and balloon cytology, chromoendoscopy, and fluorescence spectroscopy (22). 
Esophagoscopy is a procedure in which an esophagoscope is inserted through the mouth 
or nose to look inside the esophagus for abnormal areas (22). Tissue samples may be 
removed (biopsied) using this procedure for further analysis in the laboratory. Brush and 
balloon cytology are techniques in which cells from the lining of the esophagus are 
collected and observed under a microscope to check for abnormalities (22). 
Chromoendoscopy is a procedure used in conjunction with esophagoscopy. A dye is 
sprayed onto the lining of the esophagus and observations are made based upon the 
amount of staining present. Increased staining may suggest early BE (22). Fluorescence 
spectroscopy uses a special light to view tissue in the lining of the esophagus. The light 
given off by the cells in the lining of the esophagus is measured. Malignant tissue gives 
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off less light than normal tissue (22), thus confirming the presence of absence of 
carcinoma. 
1.6. Socioeconomic Contributors to Disease 
 The most commonly used SES variables in cancer research include educational 
attainment, employment, income, geographical location, and marital status (6, 9, 15, 16). 
Educational attainment relates to EAC in that unskilled workers may be prone to more 
work-place exposures (i.e.: mining) and have less healthy habits, such as smoking (15). 
Unemployment and lower income generally result in lower SES levels, which has been 
linked to higher EAC risk (17). Geographical location (urban vs. suburban environment) 
is also used in predicting cancer prevalence. Studies suggest those living in more urban 
environments are prone to greater environmental pollutants, raising their exposure levels 
to certain cancers (12). A summary of socioeconomic contributors of EAC found in 
previously published literature is located in Appendix I. 
 1.7. Role of Socioeconomic Status in Stage at Diagnosis 
The National Center of Educational Statistics defines socioeconomic status as an 
economic and sociological combined total measure of an individual’s or family’s 
economic and social position relative to others, based on determinants such as income, 
education, and occupation (26). Lower SES is known to be associated with worsened 
survival and increased incidence of cancer in the US (6, 9, 15, 16). Additionally, several 
studies conducted in the US have confirmed an association between SES and stage of 
disease diagnosis (9, 16). Several hypotheses to explain survival differences between 
social groups have been proposed including differences in tumor biology, patient co-
morbidity, stage of disease at diagnosis, access to therapy, and treatment practices (16). 
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Of these hypotheses, the most commonly cited as a potential mechanism for the observed 
relation between SES and cancer outcomes is differences in stage of disease (16). Woods 
et al. conclude in their review of literature that stage of disease at diagnosis and access to 
optimal treatment explain a portion of disparity in survival of patients with cancer (16). 
Previous cancer studies have shown a positive association between low 
socioeconomic status (specifically poverty) and later stage of cancer diagnosis (10-12, 
23-25). One study found that a lack of health insurance explained some of the observed 
differences in stage at diagnosis (10). Several studies have directly or indirectly 
addressed the effect of health insurance on stage at the time of cancer diagnosis (11, 23-
25). However, health insurance alone is unlikely to be the only explanation as the issue is 
most likely multi-factorial (25). A majority of studies that examined the impact of 
poverty on stage of cancer diagnosis used registry data, such as SEER Program data, that 
were then linked to census-tract indicators of socioeconomic status (10-12). This is the 
same approach that will be used in this study. In most of these studies, adjustment for 
socioeconomic indicators explained the majority of the observed differences in stage at 
diagnosis (11, 12).  
1.8. Area Socioeconomic Attributes 
Area socioeconomic status is defined as a “group” measure of socioeconomic 
status (such as a neighborhood or defined geographical unit). Common measures of area 
SES include unemployment rate, median household income, percent of persons below 
poverty threshold, percent of persons foreign born, percent of persons living in an urban 
area, and percent of persons with less than a high school diploma. Several studies use 
area SES because data on area SES are available for most cancer registries, however, 
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individual SES is not collected to protect patient confidentiality (27). A recent study 
conducted by the National Cancer Institute (NCI) linked five area socioeconomic 
categories to county mortality data. The socioeconomic categories were based on factors 
such as education, occupation, median family income, unemployment rate, family 
poverty rate, and housing condition. The study found that between 1950 and 1960, male 
cancer mortality was nearly 50% greater in the highest area socioeconomic group than in 
the lowest area socioeconomic group (15). However, by 1998, cancer mortality was 19% 
higher in the lowest area socioeconomic group than in the highest area socioeconomic 
group (15). The authors conclude that the socioeconomic patterns in male cancer 
mortality trends are consistent with socioeconomic patterns in cigarette smoking, a 
commonly accepted contributing factor of EAC (15). Given the latency period between 
the start of regular smoking and cancer death, it is predicted that socioeconomic 
disparities in male cancer mortality will continue to widen in the near future (15). 
1.9. Other Influences of SES on EAC 
Socioeconomic status greatly influences the type of preventive care one receives 
in the precancerous stages of EAC along with obtaining the recommended screening 
techniques (9). Even in countries with equal access to health care (such as Canada and 
Sweden), low SES is still strongly related to an increased risk of esophageal 
adenocarcinoma (9). A common pattern could be social hierarchies where it is relative 
social position or social networks within countries that matters most (9). Addressing risk 
factors such as obesity, smoking, and alcohol consumption are all primary preventive 
measures which can be taken while the disease is still in its precancerous stages. In 
addition, having good social support may lead to the prevention of these adverse health 
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behaviors (10). There is a consistent link between SES and marriage, an important form 
of social support. While marriage is hypothesized to increase income and SES (9), higher 
SES individuals also are more likely to get married (9) and hence receive social support 
from this marital partner (9). Therefore, individuals with higher SES are more likely to 
receive the social support needed to reduce risky health behaviors and stress, all of which 
contribute to better health including lower risk of factors that drive EAC. 
 A temporal shift toward earlier stage diagnosis does not explain the increasing 
incidence rate of EAC (15). Because a better prognosis is associated with earlier stage 
diagnosis, we looked at predictors of early stage disease. In this study, we examined the 
association between EAC stage and area-level SES measures including educational 
attainment, employment status, median household income, place of birth, and 



















Chapter 2: Methods 
 
 2.1. Aims 
Prior studies have demonstrated an association between SES and EAC incidence and 
prevalence (6, 9, 15, 16). The purpose of this study is to expand the literature on SES and 
EAC by improving understanding of the ways in which SES may contribute to late stage 
EAC diagnosis. Since early detection of EAC is the best predictor of treatment success, 
the study would be significant in finding which socioeconomic disparities predict a later 
diagnosis. These disparities can be targeted by public health organizations or researchers 
to implement special programs which can help lead to earlier EAC detection. 
2.2. Hypothesis 
 We hypothesize that area-level SES indicators (educational attainment, 
employment, income, place of birth, and geographical location) will be associated with 
elevated odds of late stage EAC diagnosis. In addition, we hypothesize that area-level 
median household income and unemployment will be the two strongest predictors of later 
EAC detection, possibly due to the high costs associated with EAC screening. This is in 
accordance with prior literature that indicates the importance of income and 
unemployment status on EAC outcomes. Hebert et al. found a positive association 
between area-level measures of employment status and income with the risk of EAC (17), 
while Berki et al. determined that “lack of health insurance is directly related to the 
length of unemployment” (28). 
2.3. Study Design 
The design for this study is cross-sectional, using data collected between the years 
2000 and 2007 from the Surveillance, Epidemiology, and End Results (SEER) program 
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of the National Cancer Institute. SEER is a coordinated system of population-based 
registries strategically located across the United States. These registries monitor cancer 
trends and provide timely, accurate, and continuous data on cancer incidence, the extent 
of disease at diagnosis, therapy, and patient survival. SEER gathers data on all incident 
cancers occurring in 18 geographic areas in the United States. There are nine states (New 
Mexico, Hawaii, Utah, Iowa, Connecticut, Greater California, Kentucky, Louisiana, New 
Jersey), five metropolitan areas (metropolitan Atlanta plus a sample of rural Georgia, the 
Greater Bay area [San Francisco-Oakland and San-Jose Monterey], Los Angeles, Seattle, 
Detroit), and the Alaska Tumor Registry, which together represent approximately 26 
percent of the United States population in the SEER registry (29). The SEER program 
registries routinely collect data on patient demographics, primary tumor site, tumor 
morphology and stage at diagnosis, first course of treatment, and follow-up for vital 
status. Cases are identified by reviewing hospital pathology reports and discharge 
diagnoses, death certificates, and records from pathology laboratories, oncologists, and 
radiotherapists. Vital status is determined through contact with physicians and patients, 
review of death certificates and local obituaries, and matching against the National Death 
Index and records of the Health Care Financing Administration (30). 
Census tract- and county-level socioeconomic attributes were obtained from the 
Bureau of Census through a custom data agreement with NCI. Direct linkage between 
SEER data and Bureau of Census data was made possible through unique Federal 
Information Processing Standard (FIPS) geo-coding, a unique code that matches 




2.4. FIPS Geo-coding 
 FIPS geo-coding allowed for the linkage of SEER 15 data to Bureau of Census 
data. All SEER 15 cases belonged to census-tracts which were reported and recorded in 
SEER data collection. The standard FIPS code of residence was used when this 
information was collected. The census-tract data taken from The Bureau of Census used 
the same standard FIPS code, therefore, linkage of census data to SEER data was made 
possible through this standard coding.  
2.5. Description of the Participants and Criteria for Selection 
The analysis was based on EAC cases in 12 states within the SEER 15 Registries 
(California, Connecticut, Metropolitan Detroit, Hawaii, Iowa, New Mexico, Seattle 
(Puget Sound), Utah, Georgia, Kentucky, Louisiana, New Jersey). Case definition site 
and type categories were based on International Classification of Diseases for Oncology 
(ICD-O) (3rd edition) codes: esophagus (C15.0-C15.9) and adenocarcinoma (8140-
8573). This definition identified 14,264 EAC cases in SEER 15 registries during the 
surveillance period.  
Of these 14,264 identified EAC cases, only 11,233 had a single primary tumor. 
Only cases with a single primary tumor were included in the analysis as they were 
considered newly onset and not previously diagnosed.  From these 11,233 EAC cases 
with a single primary tumor, 1,134 cases were missing data on stage at diagnosis or were 
reported as unstaged. These cases were deleted for missing information necessary for 
analysis. After deleting these cases, we were left with 10,099 total cases reporting to have 




After further review of the data, it was found that 319 cases were missing census-
tract attributes. Additionally, all 27 cases from Whatcom County, Washington were 
missing county-level attributes, and 23 more cases from various registries were missing 
data for census-tract level median family income. A total of 17 cases were missing 
county population data.  Two cases were missing census-tract level data on educational 
attainment and one case is missing census-tract level unemployment data. After 
excluding these discrepancies, an analytic dataset was created consisting of 9,710 single 
primary EAC cases with local area socioeconomic attributes (Figure 1). The figure yields 
68% of the original 14,264 EAC cases in the SEER dataset and includes 96% of 10,099 
EAC cases with specific stage at diagnosis data. 
2.6. Human Subjects 
 Approval was obtained from the University of Maryland, College Park (UMCP) 
Institutional Review Board (IRB). The study met requirements for “exempt review.” 
SEER data is publicly available after submitting a signed user agreement form which 
ensures the investigator will use the data in such manner that subjects cannot be 
identified, directly or indirectly through identifiers linked to the subjects. Approval for 
the analysis was also obtained from the NCI, SEER Custom Data User Committee. 
2.7. Description of Variables 
2.7.1. County- and Census- Tract Socioeconomic Variables 
Census-tracts are the smallest territorial unit for which population data are 
available in many countries (31). They comprise of approximately 2,500 people who 
share similar demographic attributes, such as income, employment status, home 
ownership, and location. Census-tracts tend to be more discrete about the population they 
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contain compared to counties due to demographic similarities shared among residents. On 
the other hand, county-level data is more of an aggregate. Demographic attributes are 
aggregated and are more diverse since counties do not focus on smaller sub-populations. 
More affluent counties have less cancer cases. A study done by Ezzati et al. confirmed 
that counties are the smallest unit for which mortality data are routinely available, 
allowing consistent and comparable long-term analysis of trends in health disparities 
(31). County-level data gives more of an aggregate which is generalizable to a larger 
population compared to census-tract data, which is limited in its generalizaibliltiy. Due to 
the smaller sample size, census-tract data are more discrete. Both census tract- and 
county-level data are used in the analysis as census-tract data provides more localized 
data that is homogeneous in nature (people residing in the same census-tract tend to have 
similar SES). Conversely, counties are much larger and much more socioeconomically 
heterogeneous. They account for a wider range of data since more individuals are present 
in counties than census-tracts. As a result, this may help drive statistically significant 
associations due to the increased population size.  
The analysis linked EAC cases to census tract- and county-level socioeconomic 
attributes. A list of variables used in the analysis is found in Table 1. The census-tract 
data taken from The Bureau of Census used the same standard FIPS code, therefore, 
linkage of census data to SEER data was made possible through this standard coding.  
2.7.2. Individual Case-Level Variables 
Six individual (case) level variables that have been shown to be associated with 
EAC were explored as possible confounders. A description of these variables is found in 
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Table 2. These variables all came from SEER 15 data provided by NCI. Dummy 
variables were created to better categorize age at diagnosis. 
2.7.3. Main Outcome Variable 
The main outcome variable of interest is stage at diagnosis, specifically the distant 
stage. The distant stage of EAC has the worst treatment outcome and has the highest 
mortality rate, therefore, examining SES attributes which predict distant stage diagnosis 
may help better target these disparities in future studies. 
Determining the best base model to use for data analysis was one of the primary 
focuses early on in the study. The optimal referent group for logistic regression is 
important to determine due to “stage shift” in the SEER data. A higher proportion of 
EAC cases were classified as localized, however over time, there was only a small 
decrease observed in survival time. A possible explanation could be misclassification of 
localized cases as regional due to histological similarities. To ensure a clear distinction 
between stages, it was necessary to group localized and regional cases together. This 
presented as a more appropriate referent group when conducting data analysis. Another 
model that could be informative is comparing localized stage versus distant stage only 
due to the extreme histological differences. This approach, however, reduced statistical 
power due to the elimination of the regional stage and thus was not used in the analysis. 
Combining stages when conducting analyses yielded more significant results and was 
therefore worth examining while establishing a base model. 
2.8. Variable Coding 
 After selecting the base model, the data was further explored to determine the best 
method to code variables. In preliminary analysis, it was determined that the study would 
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yield more meaningful results if variables were dichotomized. There is evidence of a 
monotonic relationship between certain variables; however, a referent group is not 
standardized in this approach. The study benefited from the use of dichotomized 
variables since a referent group was established. Certain variables, such as age, could not 
be analyzed monotonically in SAS. Dummy variables were created (which can only be 
performed in a dichotomized analysis). The outcome variable (distant stage EAC) was 
coded with the value of zero (0) in the analysis, while the referent group (localized and 
regional EAC) was coded with the value of one (1). 
2.9. Statistical Analysis 
All statistical analyses were conducted using SAS statistical software, Version 
9.2. The distribution of EAC cases by individual, census-tract, and county-level attributes 
was explored in general and by stage of diagnosis (local/regional and distant). 
Additionally, EAC cases were explored by each SEER 15 registry included in the study. 
Because of the significant findings in the individual-level analysis (Table 3), these 
variables were used as controls in the logistic regression. 
Logistic regression models were developed to estimate odds ratios and 95% 
confidence intervals for EAC cases to determine which area-level SES attributes were 
associated with late stage EAC diagnosis. A crude model along with an adjusted model  
controlling for age group (20 to 49, 50 to 69, 70 to 84, 85+ years), year of diagnosis 
(2000 to 2007), sex (male or female), and race (white or other) were created. We did not 
control for registry effects as only modest differences in localized and regional EAC rates 




Chapter 3: Results 
 
 3.1. Demographic and Registry Distributions 
Table 5 displays individual case-level demographic data for esophageal 
adenocarcinoma cases diagnosed in SEER 15 registries from 2000 to 2007, by stage at 
diagnosis. Regardless of stage at diagnosis, the vast majority of cases (> 80%) were male. 
Similarly, approximately 95% of cases were white. Approximately 64% of cases were 
married and nearly one-third were missing data on marital status. The peak age groups of 
diagnosis were 50-69 years of age (53%) followed by 70-84 years of age (33%). A small 
increase in the number of newly diagnosed EAC cases was observed between 2000 to 
2007. 
The registries with the highest rates of EAC (at least 3 per 100,000 or above) 
included Iowa, Kentucky, and Seattle (Table 4). These registries accounted for 
approximately 15% of the SEER 15 registry. The registries with the lowest rates of EAC 
(2 per 100,000 or below) included Los Angeles and Atlanta. These two registries 
accounted for approximately 17% of the SEER 15 registry. The remaining 10 registries 
(California, New Jersey, San Francisco-Oakland, Louisiana, Detroit, Connecticut, Utah, 
San Jose-Monterey, New Mexico, and Hawaii) all had EAC rates that were roughly 
around 2 per 100,000. Additionally, all registries (except Los Angeles) had half of their 
EAC cases categorized in the localized/regional stage. 
3.2. Census tract- and County-Level Attributes 
Tables 6 and 7 display census- tract and county- level area socioeconomic 
attributes for esophageal adenocarcinoma cases diagnosed in SEER 15 registries from 
2000 to 2007 by stage at diagnosis, respectively. 
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For both census- tract and county- level data, the highest percentage of cases were 
seen in the lower strata for the following area socioeconomic attributes: (1) percent of 
persons ages 25 and over that are less than a high school graduate, (2) percent of persons 
ages 16 and over who are unemployed, and (3) percent of persons below poverty 
threshold. The census- tract estimate for all three variables was around 44% for all cases 
of distant stage disease. The county- level estimate for all three variables was 
approximately 30% for all cases of distant stage disease.  
At the census- tract level, approximately 73% of distant EAC cases lived in urban 
environments, as similar to the county- level data. Additionally, 44% of distant EAC 
cases had a median household income less than or equal to $40,800, whereas the county- 
level data was more evenly distributed amongst the four strata. Both census- tract and 
county- level data shared a similar distribution for percent of persons that were foreign 
born. 
3.3. Logistic Regression 
Results from the crude and adjusted models for census-tract and county-level SES 
variables are presented in Tables 8 and 9, respectively. At the census-tract level, the only 
area-level SES variable that was significantly different from its referent group was 
percent of individuals who were foreign born. Cases living in census-tracts with > 26.6% 
foreign born individuals had statistically significant higher odds ratios of distant stage 
EAC (adjusted odds ratio (OR) = 1.14, 95% confidence interval (95% CI) from 1.02 to 




At the county-level, there were three area-level SES variables that were 
significantly different from the referent group, including percent of individuals foreign 
born, percent of individuals living in an urban environment, and median household 
income. 
In both crude and adjusted models, cases living in counties with >15.3% foreign 
born individuals had statistically significant higher odds ratios of distant stage EAC 
(adjusted odds ratio (OR) = 1.16, 95% confidence interval (95% CI) from 1.03 to 1.31) 
compared to cases living in counties with ≤ 6.7% of foreign born individuals.  
Additionally, cases living in counties with >89% of individuals living in an urban 
environment had statistically significant lower odds ratios of distant stage EAC (adjusted 
odds ratio (OR) = 0.90, 95% confidence interval (95% CI) from 0.82 to 0.98) compared 
to cases living in counties with ≤ 89% of individuals living in an urban environment. 
Finally, cases living in counties with a median household income between 
$40,800 and $45,600 had statistically significant higher odds ratios of distant stage EAC 
(adjusted odds ratio (OR) = 1.14, 95% confidence interval (95% CI) from 1.01 to 1.28) 











Chapter 4: Discussion 
 
 4.1. Discussion of Results 
The principal findings of this study were observed at the county-level. Cases who 
lived in counties with higher percentages of foreign born residents, higher percentages of 
residents living in urban settings, and lower median household income had slightly 
elevated odds of late stage EAC. The only significant association at the census-tract level 
for late stage EAC was the place of birth variable; cases who lived in census-tracts with 
greater than 26.6% foreign born residents had higher odds of developing distant stage 
EAC. 
It was hypothesized that lower SES would be a predictor of later stage EAC 
diagnosis.  Most of the socioeconomic variables used in the study are interrelated and 
may suggest possible pathways leading to later detection. For example, persons with 
lower educational attainment are more likely to be unemployed, which can result in a 
lower household income. Lower SES individuals may not be able to afford the high costs 
associated with EAC screening, therefore further delaying the detection process until 
symptoms become much more aggressive (when it may be too late). Out of all SES 
variables, it was expected that median household income and unemployment would be 
the two strongest predictors of later EAC detection. The analysis did find one level of 
median household income to be significant at the county-level, but unemployment was 
not associated with later stage EAC diagnosis in the present study. 
Living in counties with a low median household income, but not the lowest, was 
associated with later stage EAC diagnosis in this analysis. Cases living in counties with a 
median household income between $40,800 and $45,600 had statistically significant 
22 
 
higher odds ratios of distant stage EAC diagnosis compared to cases living in counties 
with a median household income less than or equal to $40,800. Hebert et al. found a 
positive association between lower income and EAC risk (17). Patients with lower 
income are less likely to get screened due to the expensive cost associated with EAC 
screening. This could explain why those with lower income are more prone to distant 
stage EAC. When comparing the second strata of median household income (40.8 to 
45.6K) with the referent group (≤ 40.8K), it was found that cases in the second strata 
(40.8 to 45.6K) had 14% greater odds of developing late stage EAC compared to cases 
who are in the referent group (≤ 40.8K). One would expect the referent group to have 
greater odds of developing late stage EAC, since income in this group is far less than the 
second strata. A possible explanation could be the poverty threshold of the geographical 
area. Certain individuals have a median household income which is slightly above the 
poverty threshold, placing them at a great disadvantage since they do not qualify for 
Medicaid and other government benefits. Those who make slightly below the poverty 
threshold may qualify for Medicaid and other government benefits such as health 
insurance (which may promote healthy screening behaviors). This could provide a 
possible explanation as to why the association at the second strata was significant. Taplin 
et al. supports the findings of the current study as the research team found a positive 
association between poverty and later stage cancer diagnosis (33).  
The analysis suggest that cases living in counties with greater than 15.3% persons 
being foreign born have a higher odds of developing distant stage EAC. Previous studies 
have noted that immigrants tend to have lower SES than native born Americans (16). 
Additionally, lower SES is linked to later stage cancer diagnosis (6, 9, 15, 16). This may 
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explain a possible pathway of later stage cancer diagnosis in foreign born EAC patients. 
Immigrants may also have a more difficult time adjusting to life in the US compared to 
native born Americans, which can directly or indirectly affect SES. Additionally, the 
findings of Hongo et al. suggest that the development of esophageal adenocarcinoma 
appears to be strongly influenced by ethnic factors (34). This supports the findings of the 
current study. 
Living in an urban environment appeared to be associated with earlier diagnosis 
of EAC in this sample. Cases living in counties with >89% of individuals living in an 
urban environment had statistically significant lower odds ratios of distant stage EAC 
compared to cases living in counties with ≤ 89% of individuals living in an urban 
environment. Falk et al. found that people living in more urban environments have a 
higher risk of developing EAC (35). The present study finds no such association for 
EAC, as living in an urban environment was protective of distant stage EAC. Falk 
explains that people living in urban environments are exposed to more environmental 
pollutants, thus raising their risk for certain cancers. A possible explanation for the 
contradictory findings of the present study could be that urban areas tend to have more 
hospitals and/or clinics, making screening readily available and accessible to residents of 
urban areas compared to cases living in suburban areas. 
The analysis examined both census tract- and county-level SES factors. There was 
a notable difference in the findings between these two levels, such that census-tract SES 
variables were not significantly associated with later stage diagnosis of EAC. Differences 
in association between county and census-tract data may be due to the homogeneity of 
SES in census-tracts and the heterogeneity of SES in counties. Census-tracts are much 
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smaller than counties and generally comprise of individuals who share similar SES 
attributes. This homogeneity may mask any significant socioeconomic association, if 
present. Conversely, counties are much larger and much more socioeconomically 
heterogeneous. They account for a wider range of data since more individuals are present 
in counties than census-tracts. As a result, this may help increase statistical confidence 
and narrow confidence intervals, which may drive more statistically significant 
associations. 
Islami et al. found that various dimensions of SES, such as education, wealth, and 
being married were all inversely related to esophageal cancer (32). The strongest inverse 
association was found with education. Compared with no education, the adjusted odds 
ratios for primary education and high school or beyond were 0.52 and 0.20, respectively. 
The present study did not find any significant associations between education and late 
stage EAC, however, wealth (defined as median household income) was significant at the 
county-level. The social support provided by a life partner may explain why Islami et al. 
found that those who are married are less likely to develop EAC. Additionally, a 
statistically significant association between being married and earlier stage diagnosis was 
found in the individual-level analysis of the current study which further supports the 
findings of Islami. 
Jansson et al. found that the risk of esophageal adenocarcinoma increased with 
decreasing SES; unskilled workers had 3.7-fold and 2.1-fold increased risks, respectively, 
compared with age- and sex-comparable professionals (9). Jansson et al. defines SES as 
the type of skill one possessed (professional, intermediate, assistant, skilled, and 
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unskilled). Due to the difference in SES definitions, Jansson et al. cannot be used to show 
consistency with the current study. 
4.2. Strengths 
 A major strength of the study is the large sample size provided by SEER. SEER 
data accounts for a large sub-set of the US population, making it one of the largest cancer 
databases available for public use. SEER data can also be accessed through the Internet, 
making it very convenient for researchers. The large sample size allowed for several 
deletions of individuals having incomplete data records. This strengthened the quality of 
the analytic data set since each data entry had a complete list of research variables. 
Furthermore, the large sample size allowed for narrower confidence intervals in statistical 
analyses, suggesting a truer association among odds ratios.  
4.3. Limitations 
A major limitation of the study would be the cross-sectional design, as it prevents 
us from deriving causality between SES variables and EAC. Additionally, the study is 
restricted to area-level SES measures and does not account for individual-level SES. 
Most registry based studies do not use individual SES measures since the cancer registry 
does not capture this information. Most individual-level data comes from medical records 
which are required by law to de-identify patients to protect their privacy and 
confidentiality. Using individual-level data can compromise patient confidentiality; 
therefore, area SES serves as a good proxy since people who live in the same 
neighborhood/area tend to share similar SES levels. Conversely, area SES does not serve 
as a reliable proxy for individual data. SES measures at the census tract- and county-level 
may operate in different ways than at the individual-level. County X may comprise 
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primarily of residents whose median household income is below the poverty threshold. 
There may be a small number of individuals who reside in the same county whose 
income is significantly greater than the poverty threshold, therefore, area SES measures 
cannot be generalized to these individuals. Thus, generalizing area SES measures at the 
individual-level is inaccurate and should be avoided.  
Although adjustment for sex, race, and year of diagnosis had no effect on 
statistically significant associations with place of birth, income, and population density, 
we cannot dismiss the possibility of residual confounding due to individual-level 
attributes such as income, health insurance status, and smoking status. Additionally, we 
cannot dismiss the possibility of residual confounding due to registry effects, although 
none were observed in the present study. 
The present study only examined the association between area-level SES and late 
stage EAC diagnosis.  However,  low SES also influences risk factors of EAC (which 
then ultimately leads to disease).  Future follow-up studies would benefit from separate 
sub-analyses looking at individual-level SES data (if available) as well as the influence of 
low SES on EAC risk factors. 
4.4. Public Health Significance 
This study provides insight into area-level attributes associated with stage at 
diagnosis for esophageal adenocarcinoma. The information in this report may inform 
cancer control efforts if area-level income, population density, and nativity can be used as 
a basis to target EAC screening, prevention, and early treatment resources, which could 
help reduce the burden of this disease. More research is recommended to determine if 
these finding can be replicated at the individual-level. 
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Although the outcome for advanced stage esophageal adenocarcinoma is poor, the 
early detection and treatment of early stage disease is usually associated with a much 
better outcome (13). Until recently, esophagectomy has been the treatment of choice in fit 
patients, however, morbidity is significant and has encouraged the development of newer 
endoscopic treatments that preserve the esophagus such as ablation and mucosal resection 
(13). Promising results are foreseen, and endoscopic methods may provide as an 
alternative treatment for early esophageal adenocarcinoma. Minimally invasive 
techniques for esophageal resection have also been shown to be feasible, although there is 
only limited evidence that they reduce postoperative morbidity (13). Further data is 
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Table 1. County- and Census- Tract Socioeconomic Variables, esophageal adenocarcinoma 
incident cases, SEER 15 registries, 2000-2007 
 
Variable Format 
Education Percent of persons ages 25 and 
over that are less than a high 
school graduate 
> 26.7% 
> 19.3 to 26.7% 
15.4 to 19.3% 
≤ 15.4% 
 
Employment Percent of persons ages 16 and 
over who are unemployed 
> 8.2 
> 6.0 to 8.2% 
4.8 to 6.0% 
≤ 6.0% 
 
Income Median household income 
> 54K 
> 45.6 to 26.6K 
40.8 to 45.6K 
≤ 40.8K 
 
Poverty Percent of persons below poverty 
threshold 
> 17.7% 
> 12.0 to 17.7% 
8.4 to 12.0% 
≤ 8.4% 
 
Birthplace Percent foreign born 
> 26.7% 
> 19.3 to 26.7% 
15.4 to 19.3% 
≤ 15.4% 
 
Environment Percent of people in an area that 
are living in an urban 
environment 
100% 








Age at diagnosis Categorized into 4 groups using dummy 
variables. Group 1 includes ages 20-49; 
Group 2 includes ages 50-69; Group 3 
includes ages 70-84; and Group 4 
includes ages 85 + 
Race White Non-Hispanic; all other races will 
be considered “other” for analyses as 
EAC is primarily a disease of white males 
Gender Male/Female 
Year of diagnosis SEER 15 covers years 2000-2007 
Marital Status Married, single, widowed, separated, 
divorced, unknown 
Health Insurance Status No insurance, some insurance, missing 













Table 3. Logistic regression model of the association between stage at diagnosis and individual-

























Table 5. Individual case-level demographic attributes by stage at diagnosis, esophageal 









Table 6. Census tract- area socioeconomic attributes by stage at diagnosis, esophageal 





Table 7. County- level area socioeconomic attributes by stage at diagnosis, esophageal 






Table 8. Logistic regression model of the association between stage at diagnosis and census tract 








Table 9. Logistic regression model of the association between stage diagnosis and county level 








Appendix 1: Literature Review Summary 
Variable Level Risk Factor Conclusion 
 
References 
Age Individual Yes Studies consistently show that the incidence of EAC increases with age. Data 
from both SEER and the Danish Cancer Registry demonstrate that the incidence 
rate of EAC increases with age until it peaks at 75-79 years of age and declines 
thereafter. 
Bollschweiler et al. 
Singh et al. 
Woods et al. 
Falk et al. 
Education County 
Census 
No The strongest inverse association between EAC risk and various SES variables 
was found to be education. There are indications that low SES, based on 
measures of education, might increase the risk of EAC, but inconsistent results 
and the use of different measures of socioeconomic status makes comparisons 
and interpretations difficult. 
Islami et al. 
Janson et al. 
Employment County 
Census 
No Unemployment generally results in lower SES levels, which has been linked to 
higher EAC risk. 
Hebert et al. 
Environment County 
Census 
No One study suggests those living in more urban environments are prone to 
greater environmental pollutants, raising their exposure levels to certain 
cancers. 
Falk et al. 
Downing et al. 
Gender Individual Yes It is estimated that the incidence of EAC is approximately six to eight fold 
greater in men than in women. 




Individual No One study found that a lack of health insurance explained some of the observed 
differences in stage at EAC diagnosis. Several studies have directly or indirectly 
addressed the effect of health insurance on stage at the time of cancer diagnosis. 
However, health insurance alone is unlikely to be the only explanation. 
Additionally, unemployed individuals are less likely to have health insurance, 
which would further delay screening efforts. One study determined that “lack of 
health insurance is directly related to the length of unemployment.” 
Berki et al. 
Taplin et al. 
Bradley et al. 
Roetzheim et al. 
Ayanian et al. 
Garmon et al. 
Income County 
Census 
No Lower income generally results in lower SES levels, which has been linked to 
higher EAC risk. 
Hebert et al. 
Marital 
Status 
Individual No One study found a greater than two-fold increase in risk of EAC in individuals 
without a life partner compared to individuals who had a life partner. Another 
study found that the social support provided by a life partner may explain why 
those who are married are less likely to develop EAC. Additionally, marriage is 
hypothesized to increase social support and income and reduce risky behavior 
and stress, all factors contributing to better health. 
Janson et al. 
Hebert et al. 








No Development of esophageal adenocarcinoma appears to be strongly affected by 
ethnic factors, with populations resident at the west end of the Eurasian 
continent, such as Anglo-Celtics, being more prone to the condition. 
Hongo et al. 
Poverty County 
Census 
No Previous cancer studies have shown a positive association between low 
SES (specifically poverty) and later cancer diagnosis. A majority of studies that 
examined the impact of poverty on stage of cancer diagnosis used registry that 
were then linked to census tract indicators of socioeconomic status. In most of 
these studies, adjustment for socioeconomic indicators explained the majority of 
the observed differences in stage at diagnosis. 
Taplin et al. 
Bradley et al. 
Lannin et al. 
Roetzheim et al. 
Ayanian et al. 
Garmon et al. 
Race Individual Yes The average annual incidence rate for EAC for white men was double that of 
Hispanic men (4.2 versus 2.0/100,000/year). This rate was also four times 
higher than that seen in black, Asian/Pacific Islanders and Native Americans. 
Kubo et al. 
Year of 
Diagnosis 
Individual No Despite efforts to increase screening of all risk individuals, no temporal 
improvement in stage at diagnosis profile for EAC has been seen. 
Cooper et al. 
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